Severe hepatic side effects of ezetimibe
- Clin Gastroenterol Hepatol. 2006 Jul;4(7):908-11. doi: 10.1016/j.cgh.2006.04.014.
- 1. Department of Gastroenterology, St. Antonius Hospital, Nieuwegein, The Netherlands. [email protected]
Background and aims: Ezetimibe was introduced recently as a new class of cholesterol-lowering drugs. Until now only limited increases of transaminase levels were reported.
Methods: We studied 2 patients with severe hepatic side effects of ezetimibe in a general community hospital.
Results: Ezetimibe may lead to 2 distinct types of severe hepatic side effects.
Conclusions: Ezetimibe may rarely cause hepatotoxicity, severe cholestatic hepatitis, or acute autoimmune hepatitis.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Drug MetaboliteResearch Areas: Metabolic Disease
-
target: Drug MetaboliteResearch Areas: Metabolic Disease